Naples, Florida Aug 29, 2025 (Issuewire.com) - Mark A. Nedelman, MS, MBA, continues to advance the service sector supporting the biopharmaceutical industry through his leadership of ANEWCRO, a nonclinical contract research organization (CRO), dedicated to delivering innovative solutions and discovery support for clients across the biopharmaceutical industry and academic institutions. With more than 40 years of experience in drug discovery and development, Mark leverages his extensive expertise to position ANEWCRO as a trusted partner, offering tailored services and expert guidance that redefine the role of contract research organizations in todays evolving landscape.

Mark holds a Bachelor of Science in Biology and a Master of Science in Biology from the University of Cincinnati, as well as an MBA from Northeastern University. His diverse experience began in academia at Massachusetts General Hospital, where he contributed to groundbreaking research that laid the foundation for future innovations. Since then, Mark has held pivotal roles in drug development at leading companies such as Centocor and CeleCor Therapeutics.

Transitioning into the CRO sector, Mark served as General Manager at Charles River Laboratories (CRL) and later as CEO of Ekam Imaging. His most recent role before founding ANEWCRO was as the CEO of Biomere, where he spearheaded a growth strategy that successfully led to the companys acquisition by Joinn Labs in 2019. This extensive experience in both corporate and research environments allows Mark to understand the unique challenges faced by biopharmaceutical companies and to provide solutions that are both practical and innovative.

At ANEWCRO, Mark and his team are committed to delivering high-quality services that accelerate the drug discovery process. Marks vision is to foster collaboration between researchers and industry, paving the way for groundbreaking advancements in medicine.  Mark has co-authored over 50 peer-reviewed publications and contributed to three book chapters. He is also actively involved in the field of regenerative medicine as a Trustee of the Xenotherapeutics Foundation, further demonstrating his commitment to advancing scientific research and innovation.

ANEWCRO has established itself as a leader in the CRO industry, driven by Mark Nedelmans vast expertise and unwavering passion for advancing biopharmaceutical research.

Learn More about Mark A. Nedelman:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/85024216-Mark-Nedelman-General-Practitioner

About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept their insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.